Tadalafil 20 mg Troche
Published February 5, 2020 · Recall initiated: December 18, 2019
Summary
FDA records drug Class II recall D-0818-2020, published February 5, 2020 and initiated December 18, 2019. Recalling firm: MPRX, Inc. dba Medical Park Pharmacy; Status: Terminated; Reported quantity: 9 bottles; Lot: Lots: 61137:42 Use by: 03/08/2020; 61324:99 Use by: 04/04/2020; 60856:42 Use by: 02/02/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- MPRX, Inc. dba Medical Park Pharmacy
- Distributor
- TX
- Lot
- Lots: 61137:42 Use by: 03/08/2020; 61324:99 Use by: 04/04/2020; 60856:42 Use by: 02/02/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
Questions about this recall
Was Tadalafil 20 mg Troche recalled?
Yes. FDA published recall D-0818-2020 on February 5, 2020. Reported hazard: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
What should I do if I have this product?
Voluntary: Firm initiated · Letter